These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19270204)
21. Treatment of metabolic syndrome in peritoneal dialysis patients. Li PK; Kwan BC; Ko GT; Chow KM; Leung CB; Szeto CC Perit Dial Int; 2009 Feb; 29 Suppl 2():S149-52. PubMed ID: 19270205 [TBL] [Abstract][Full Text] [Related]
22. Cardiovascular risk in peritoneal dialysis. Prichard S Contrib Nephrol; 2003; (140):82-90. PubMed ID: 12800347 [TBL] [Abstract][Full Text] [Related]
23. A story half untold: adiposity, adipokines and outcomes in dialysis population. Kwan BC; Beddhu S Semin Dial; 2007; 20(6):493-7. PubMed ID: 17991193 [TBL] [Abstract][Full Text] [Related]
24. Glucose and Insulin Response to Peritoneal Dialysis Fluid in Diabetic and Nondiabetic Peritoneal Dialysis Patients. Oba I; Mori T; Chida M; Kurasawa N; Naganuma E; Sato E; Koizumi K; Sato S; Tsuchikawa M; Ito S Adv Perit Dial; 2015; 31():11-6. PubMed ID: 26714381 [TBL] [Abstract][Full Text] [Related]
25. Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis. Lambie M; Bonomini M; Davies SJ; Accili D; Arduini A; Zammit V Trends Endocrinol Metab; 2021 Sep; 32(9):721-730. PubMed ID: 34266706 [TBL] [Abstract][Full Text] [Related]
26. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients. Canbakan M; Sahin GM Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442 [TBL] [Abstract][Full Text] [Related]
33. Insulin resistance and the metabolic syndrome. Lann D; Gallagher E; Leroith D Minerva Med; 2008 Jun; 99(3):253-62. PubMed ID: 18497723 [TBL] [Abstract][Full Text] [Related]
34. The association between metabolic syndrome components and the development of atherosclerosis. Aboonabi A; Meyer RR; Singh I J Hum Hypertens; 2019 Dec; 33(12):844-855. PubMed ID: 31636352 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic tools for dyslipidemia in peritoneal dialysis patients. Scarpioni R J Nephrol; 2009; 22(1):46-58. PubMed ID: 19229818 [TBL] [Abstract][Full Text] [Related]
37. Prevention of renal osteodystrophy in peritoneal dialysis. Weinreich T Kidney Int; 1998 Dec; 54(6):2226-33. PubMed ID: 9853289 [TBL] [Abstract][Full Text] [Related]
38. [Dyslipidemia and stroke in patients with chronic kidney disease]. Kes P; Bašić-Kes V; Furic-Cunko V; Mesar I; Bašić-Jukić N Acta Med Croatica; 2014 Apr; 68(2):141-9. PubMed ID: 26012152 [TBL] [Abstract][Full Text] [Related]
39. Chronic kidney disease as a metabolic syndrome with malnutrition--need for strict control of risk factors. Shoji T; Nishizawa Y Intern Med; 2005 Mar; 44(3):179-87. PubMed ID: 15805704 [TBL] [Abstract][Full Text] [Related]
40. Intraperitoneal administration of insulin during peritoneal dialysis of diabetics with terminal renal failure. Anderson KE; Petersen PH Int J Artif Organs; 1981 Jul; 4(4):162-7. PubMed ID: 7035377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]